GW Pharma CEO explains company's plan for CBD-based epilepsy drug



GW Pharmaceuticals CEO Justin Gover tells Jim Cramer the company plans to launch the first CBD-based epilepsy drug in Europe ‘over the next year or two.’

Be the first to comment

Leave a Reply

Your email address will not be published.


*